Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
2002 5
2003 6
2004 8
2005 9
2006 4
2007 12
2008 6
2009 14
2010 10
2011 7
2012 1
2015 1
2019 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon-like peptide-1 receptor agonist BI 456906.
Jungnik A, Arrubla Martinez J, Plum-Mörschel L, Kapitza C, Lamers D, Thamer C, Schölch C, Desch M, Hennige AM. Jungnik A, et al. Among authors: thamer c. Diabetes Obes Metab. 2023 Apr;25(4):1011-1023. doi: 10.1111/dom.14948. Epub 2023 Jan 30. Diabetes Obes Metab. 2023. PMID: 36527386 Clinical Trial.
The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder.
Grimm S, Keicher C, Paret C, Niedtfeld I, Beckmann C, Mennes M, Just S, Sharma V, Fuertig R, Herich L, Mack S, Thamer C, Schultheis C, Weigand A, Schmahl C, Wunder A. Grimm S, et al. Among authors: thamer c. Eur Neuropsychopharmacol. 2022 Dec;65:44-51. doi: 10.1016/j.euroneuro.2022.10.009. Epub 2022 Nov 4. Eur Neuropsychopharmacol. 2022. PMID: 36343427 Free article. Clinical Trial.
Interscapular fat is strongly associated with insulin resistance.
Thamer C, Machann J, Staiger H, Müssig K, Schwenzer N, Ludescher B, Machicao F, Claussen C, Fritsche A, Schick F, Stefan N, Häring HU. Thamer C, et al. J Clin Endocrinol Metab. 2010 Oct;95(10):4736-42. doi: 10.1210/jc.2009-1942. Epub 2010 Jul 21. J Clin Endocrinol Metab. 2010. PMID: 20660049 Clinical Trial.
Insulin sensitivity and liver fat: role of iron load.
Haap M, Machann J, von Friedeburg C, Schick F, Stefan N, Schwenzer NF, Fritsche A, Häring HU, Thamer C. Haap M, et al. Among authors: thamer c. J Clin Endocrinol Metab. 2011 Jun;96(6):E958-61. doi: 10.1210/jc.2010-2682. Epub 2011 Mar 23. J Clin Endocrinol Metab. 2011. PMID: 21430023
Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease.
Frölich L, Wunderlich G, Thamer C, Roehrle M, Garcia M Jr, Dubois B. Frölich L, et al. Among authors: thamer c. Alzheimers Res Ther. 2019 Feb 12;11(1):18. doi: 10.1186/s13195-019-0467-2. Alzheimers Res Ther. 2019. PMID: 30755255 Free PMC article. Clinical Trial.
[Reduced insulin effect in subclinical fatty liver].
Thamer C, Machann J, Haap M, Bachmann O, Wietek B, Dahl D, Tschritter O, Fritsche A, Jacob S, Schick F, Stumvoll M, Häring H. Thamer C, et al. Dtsch Med Wochenschr. 2004 Apr 16;129(16):872-5. doi: 10.1055/s-2004-823032. Dtsch Med Wochenschr. 2004. PMID: 15083407 German.
80 results